NEW YORK (360Dx) – Beckman Coulter Diagnostics said today that it has received US Food and Drug Administration clearance for its automated Access AMH test, a paramagnetic particle chemiluminescent immunoassay for the quantitative determination of anti-Müllerian hormone levels.

Beckman noted that the anti-Müllerian hormone test aids healthcare providers in the assessment of a woman’s ovarian reserve and helps guide the clinical management of women struggling with infertility or planning to become pregnant later in life.